BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32675093)

  • 1. Approach to red blood cell antibody testing during pregnancy: Answers to commonly asked questions.
    Minuk L; Clarke G; Lieberman L
    Can Fam Physician; 2020 Jul; 66(7):491-498. PubMed ID: 32675093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Rh alloimmunization.
    Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
    J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guideline for prevention of RhD alloimmunizationin RhD negative women].
    Lubušký M; Procházka M; Simetka O; Holusková I
    Ceska Gynekol; 2013 Apr; 78(2):132-3. PubMed ID: 23710977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Spontaneous antepartal RhD alloimmunization].
    Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
    Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically silent massive fetomaternal hemorrhage: important lessons from an illustrative case.
    Post GR; Lazarchick J; Singh ZN
    Lab Hematol; 2012 Jun; 18(2):11-3. PubMed ID: 22709788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three cases of massive fetomaternal hemorrhage presenting without clinical suspicion.
    Pourbabak S; Rund CR; Crookston KP
    Arch Pathol Lab Med; 2004 Apr; 128(4):463-5. PubMed ID: 15043456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of fetomaternal rhesus-D allo-immunization. Practical aspects].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S123-1S130. PubMed ID: 16495838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receipt of RhD-positive whole blood for life-threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti-D.
    Sherwood MR; Clayton S; Leeper CM; Yazer M; Moise KJ; Granger ME; Spinella PC
    Transfusion; 2024 May; 64 Suppl 2():S100-S110. PubMed ID: 38563495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possibility to identify fetomaternal haemorrhage].
    Studnicková M; L'ubuský M; Ordeltová M; Procházka M
    Ceska Gynekol; 2010 Oct; 75(5):443-6. PubMed ID: 21374922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The scientific basis of antenatal prophylaxis.
    Urbaniak SJ
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():11-8. PubMed ID: 9863973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The importance of antenatal immunoprophylaxis for prevention of hemolytic disease of the fetus and newborn].
    Starcević M; Mataija M; Sović D; Dodig J; Matijević R; Kukuruzović M
    Acta Med Croatica; 2011 Mar; 65(1):49-54. PubMed ID: 21568074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inaccurate doses of R immune globulin after rh-incompatible fetomaternal hemorrhage: survey of laboratory practice.
    Ramsey G;
    Arch Pathol Lab Med; 2009 Mar; 133(3):465-9. PubMed ID: 19260751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Standardization of the quantitative flow cytometric test with anti-D antibodies for fetomaternal hemorrhage in RhD negative women].
    Spychalska J; Uhrynowska M; Pyl H; Klimczak-Jajor E; Kopeć I; Peciakowska M; Gutowska R; Gawlak M; Słomska S; Dąbkowska S; Szczecina R; Dębska M; Brojer E
    Ginekol Pol; 2015 Jul; 86(7):486-93. PubMed ID: 26376524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of fetomaternal hemorrhage.
    Kim YA; Makar RS
    Am J Hematol; 2012 Apr; 87(4):417-23. PubMed ID: 22231030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two cases of asymptomatic massive fetomaternal hemorrhage.
    Peedin AR; Mazepa MA; Park YA; Weimer ET; Schmitz JL; Raval JS
    Transfus Apher Sci; 2015 Apr; 52(2):208-10. PubMed ID: 25736586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guideline for prevention of RhD alloimmunization in RhD negative women].
    Lubuský M; Procházka M; Simetka O; Holusková I
    Ceska Gynekol; 2010 Aug; 75(4):323-4. PubMed ID: 20925231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow Cytometry in Detection of Fetal Red Blood Cells and Maternal F Cells to Identify Fetomaternal Hemorrhage.
    Farias MG; Dal Bó S; Castro SM; da Silva AR; Bonazzoni J; Scotti L; Costa SH
    Fetal Pediatr Pathol; 2016; 35(6):385-391. PubMed ID: 27494244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do Rh-negative women with first trimester spontaneous abortions need Rh immune globulin?
    Hannafin B; Lovecchio F; Blackburn P
    Am J Emerg Med; 2006 Jul; 24(4):487-9. PubMed ID: 16787810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological principle of development of red blood cell alloimmunization in pregnancy, hemolytic disease of the fetus and prevention of RhD alloimmunization in RhD negative women.
    Roubalová L; Lubušký M
    Ceska Gynekol; 2020; 85(6):408-416. PubMed ID: 33711901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.